In 2015 Stallergenes and Greer united to form a worldwide leader in allergy immunotherapy, an innovative and sustainable group carrying the name of Stallergenes Greer. Capitalizing on a very strong heritage in both the US and Europe, we are leveraging our complementary capabilities in every area of our activities from research to professional healthcare partnerships.
We have the opportunity to change the way that people think about allergy.
At the centre of everything we do, are the people we help....
Our executive team is drawn from the leadership of Stallergenes and Greer together with external biopharmaceutical talent. Together they form a forward-thinking and collaborative multi-cultural group dedicated to leading our employees and partners toward our vision of worldwide freedom from allergy.